OncoMatch

OncoMatch/Clinical Trials/NCT07790718

Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer

Is NCT07790718 recruiting? Yes, currently enrolling (Sep 2026). This NA trial studies non-drug interventions for colon polyp.

NARecruitingCity of Hope Medical CenterNCT07790718Data as of Sep 2026

This clinical trial evaluates the effects of exercise therapy on signs of colorectal cancer in colon tissue and blood in people who completed pelvic radiation therapy for prostate cancer. People who get radiation in the pelvic area have a higher chance of developing colon cancer years later. This is because radiation can cause new mutations and inflammation. Research shows that exercise lowers colon cancer risk by about 30%. The results of this trial may help researchers better understand how exercise affects the development of colorectal cancer in patients who were treated with pelvic radiation therapy for prostate cancer.

Check if I qualify

Extracted eligibility criteria

Cancer type

Colorectal Cancer

Prostate Cancer

Disease stage

Excluded: Stage DISTANT METASTATIC MALIGNANCY

Distant metastatic malignancy of any kind [excluded]

Demographics

Ages 40–80
Male only

Prior therapy

Must have received: radiation therapy — pelvic radiotherapy for prostate cancer

Completed pelvic radiotherapy 12-20 months ago

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

  • City of Hope Medical Center · Duarte, California
  • City of Hope at Irvine Lennar · Irvine, California

Showing up to 5 US sites.

See all sites on ClinicalTrials.gov →

Frequently asked questions

Is NCT07790718 currently recruiting?

Yes, this trial is currently recruiting patients.

Is prior treatment required for enrollment?

Yes. Patients must have previously received radiation therapy.

Is there an age limit?

Yes. Patients must be 80 years or younger and at least 40 years old.

Is this trial open to female patients?

No. This trial enrolls male patients only.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify